Anchiano Therapeutics

Anchiano is focused on the discovery, development, and commercialization of novel therapies to treat cancer in areas of unmet need. The company focuses on the development of clinical therapies for the treatment for non-muscle-invasive bladder cancer, advanced malignant neoplasms, metastatic lung cancer and metastatic liver cancer. The company is currently advancing its drug development programs, including the initiation of a pivotal trial of the company’s first-in-class and first-of-its-kind gene therapy in development for treatment of bladder cancer.